Novartis Ag (NVS) Shares Outstanding (2018 - 2025)

Novartis Ag's (NVS) quarterly Shares Outstanding came in at $1.9 billion in Q4 2025, down 3.39% year-on-year from $2.0 billion in Q4 2024, and down 3.39% quarter-over-quarter from $2.0 billion in Q4 2024.

Novartis Ag (NVS) Shares Outstanding (2018 - 2025) Analysis & Trends

Novartis Ag has disclosed Shares Outstanding across 8 years of filings, most recently posting $1.9 billion for Q4 2025.

  • Shares Outstanding for Q4 2025 came in at $1.9 billion, down 3.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.9 billion (down 3.39% YoY), and the FY2025 annual result was $1.9 billion, down 3.39% from the prior year.
  • Shares Outstanding came in at $1.9 billion for Q4 2025 at Novartis Ag, down from $2.0 billion in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.2 billion in Q4 2021 to a low of $1.9 billion in Q4 2025.
  • The 5-year median for Shares Outstanding is $2.0 billion (2023), against an average of $2.1 billion.
  • Across the five-year window, Shares Outstanding fell 0.97% in 2021 and dropped 5.16% in 2022, its largest moves.
  • Novartis Ag's Shares Outstanding stood at $2.2 billion in 2021, then declined by 5.16% to $2.1 billion in 2022, then decreased by 3.57% to $2.0 billion in 2023, then dropped by 3.37% to $2.0 billion in 2024, then declined by 3.39% to $1.9 billion in 2025.
  • The last three Shares Outstanding figures came in at $1.9 billion (Q4 2025), $2.0 billion (Q4 2024), and $2.0 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 943.50 Mn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 3.12 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 1.77 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 3.58 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 539.70 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 1.24 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 9.64 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.92 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2025 1.91 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2024 1.98 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn
Dec 31, 2023 2.04 Bn